MEN'S DROPPER-SOLUTION PROJECT
KINODIN supports private label 5% minoxidil topical solution projects for men-focused brands, distributors and pharmaceutical partners. This product direction combines an agreed 5% minoxidil specification with a 60ml bottle and dropper dispensing system, subject to formula, concentration basis, package compatibility and destination-market review. We coordinate formula assessment, dropper-package development, private label artwork, finished-product testing, project-specific documentation and commercial launch planning. Intended users, directions, warnings, claims and market authorization must be confirmed for the specific finished product and country before commercial distribution.
The original page combines “5% minoxidil oil,” “100% pure castor oil,” “hair serum,” “hair lotion” and “growth cream.” These descriptions cannot all accurately identify one finished product. Before this new page is published, the formula record and product COA should confirm that the product actually contains minoxidil at the stated concentration.
Use the new topical-solution positioning, verify concentration, remove “organic,” “all natural,” “100% castor oil” and cosmetic-only terminology, and place the product under Minoxidil Topical Solution.
Remove every minoxidil reference, concentration and medicinal claim. Rename it as a cosmetic castor-oil scalp serum and move it to Hair Growth Serum or Scalp Treatment Oil.
| Specification | Current direction | Required confirmation |
|---|---|---|
| Active | 5% minoxidil | Raw-material identity, concentration basis and finished-product assay |
| Dosage form | Topical solution | Complete solvent and inactive-ingredient system |
| Intended users | Men-focused | Age range, directions, warnings and label according to market pathway |
| Net contents | 60ml | Actual fill, bottle capacity and market declaration |
| Dispenser | Dropper pipette | Material compatibility, output, seal and leakage |
| Castor oil | Not confirmed | Actual inclusion, grade, percentage, technical role and compatibility |
A 5% minoxidil solution requires a technically suitable system that maintains the active in the required physical state. A high-viscosity oil cannot be assumed to dissolve or stabilize minoxidil simply because both ingredients are marketed for hair care. If castor oil is requested, the development team must evaluate its true level and impact on solubility, crystallization, viscosity, dispensing and stability.
The bottle, pipette, bulb, wiper and threaded closure must be compatible with the complete formula. A thicker or oil-containing liquid may behave differently from a conventional solution when drawn into and released from the pipette.
Glass or compatible plastic assessed for fill volume, product contact and protection.
Material, uptake, release, graduation and repeated-use performance evaluated.
Fit, sealing, leakage, product residue and user handling checked.
The final test plan depends on the agreed formula, concentration, package and destination-market specification. It should evaluate both the topical solution and the dropper system.
“Organic,” “100% pure castor oil,” “all natural” and “free from harmful chemicals” should be removed unless the complete formula and certification basis support them. A product containing minoxidil and a solvent system cannot be presented as 100% pure castor oil.
The page should also avoid guaranteed regrowth, follicle stimulation, deep penetration, safe for all hair types, fixed four-to-six-week results and treatment claims copied from other products. Finished-product claims must follow the applicable evidence and market pathway.
Private label options may include bottle color, dropper style, label, direct bottle decoration, carton, insert and batch coding. MOQ depends on the actual formula, bottle and dropper components, printing, carton, testing and documentation. A one-piece sample policy should not be confused with commercial production MOQ.
Sample availability and lead time are confirmed after the product identity is resolved. A castor-oil cosmetic sample and a 5% minoxidil topical-solution sample are not interchangeable projects.
Available documents depend on the confirmed formula, manufacturing party, packaging system, batch and country of sale. The project file may include formula information, raw-material documents, safety data, batch COA, test reports, packaging specifications and manufacturing records, depending on scope.
The customer and its regulatory partner must establish the applicable registration or marketing-authorization route, authorization holder, importer, local responsible party, intended users, directions, warnings and claims. Generic ingredient documents do not authorize a customized finished product.
The actual formula and COA must resolve this before publication. The new page assumes a confirmed 5% minoxidil topical solution; otherwise all minoxidil content must be removed.
We recommend “topical solution.” “Hair oil” suggests an ordinary cosmetic product and does not accurately define the dosage form.
Not while also being a multi-ingredient 5% minoxidil solution. Any castor-oil content must be stated as its actual percentage and technically evaluated.
The claim should not be used unless the complete product and applicable certification basis support it. An organic botanical ingredient does not make the full formula organic.
It is the current package concept. Final bottle capacity, actual fill and label declaration require confirmation.
Bottle, bulb, pipette, collar, label and carton options can be evaluated subject to formula compatibility, component availability and MOQ.
MOQ depends on whether the project uses a confirmed stock formula or custom development, plus bottle, dropper, decoration, carton, testing and documentation.
Sample options are confirmed after the formula identity and dropper package are selected. Sample approval does not replace stability, batch testing or market authorization.
The document list is confirmed for the actual formula, manufacturing party, packaging, batch and destination country.
Send the confirmed formula, destination country, intended users, dropper-bottle preference, private label requirements and estimated quantity. KINODIN will review feasibility, packaging, testing, documentation and the next sampling step.
Minoxidil Topical Products Minoxidil Topical SolutionRegulatory Notice: Minoxidil-containing products may be regulated as medicinal products in the destination market. Formula, intended users, labeling, claims, directions, warnings, packaging and supporting documents must be evaluated for the intended country. KINODIN does not represent that a customized finished product is authorized in any specific market unless supported by the applicable authorization documents.
contact us
contact us for free sample !
Copyright © 2026 Foshan Younik Cosmetics Co., Limited. All Rights Reserved.